Department of Obstetrics and Gynaecology, Centre for Reproductive Medicine, West China Second University Hospital, Key Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education, Sichuan University, Chengdu, People's Republic of China.
Department of Anesthesia, Sichuan Integrative Medicine Hospital, Sichuan Academy of Chinese Medicine Science, Chengdu, People's Republic of China.
Mol Cell Biol. 2021 May 21;41(6):e0036320. doi: 10.1128/MCB.00363-20.
The aim of current study was to explore the mechanism of microRNA 142-5p (miR-142-5p) in cervical cancer through mediating the phosphoinositol-3-kinase adaptor protein 1 (PIK3AP1)/PI3K/AKT axis. To this end, reverse transcription-quantitative PCR (RT-qPCR) and Western blot analysis results revealed that miR-142-5p was poorly expressed, whereas PIK3AP1 was highly expressed, in cervical cancer tissues and cells. Furthermore, miR-142-5p was hypermethylated in cervical cancer, as reflected by methylation-specific PCR (MS-PCR) and chromatin immunoprecipitation (ChIP) assessment of enrichment of DNMT1/DNMT3a/DNMT3b in the promoter region of miR-142-5p. A target binding relationship between miR-142-5p and PIK3AP1 was established, showing that miR-142-5p targeted and inhibited the expression of PIK3AP1. Loss- and gain-of-function assays were conducted to determine the roles of miR-142-5p and PIK3AP1 in cervical cancer cells. CCK-8, flow cytometry, and Transwell assay results revealed that overexpression of miR-142-5p in cervical cancer cells downregulated PIK3AP1 and inhibited the PI3K/AKT signaling pathway, leading to reduced proliferation, migration, and invasion capacity of cervical cancer cells but enhanced apoptosis. Collectively, epigenetic regulation of miR-142-5p targeted PIK3AP1 to inactivate the PI3K/AKT signaling pathway, thus suppressing development of cervical cancer, which presents new targets for the treatment of cervical cancer.
本研究旨在探讨微小 RNA 142-5p(miR-142-5p)通过介导磷酸肌醇-3-激酶衔接蛋白 1(PIK3AP1)/PI3K/AKT 轴在宫颈癌中的作用机制。为此,逆转录定量 PCR(RT-qPCR)和 Western blot 分析结果显示,miR-142-5p 在宫颈癌组织和细胞中表达水平较低,而 PIK3AP1 表达水平较高。此外,通过甲基化特异性 PCR(MS-PCR)和染色质免疫沉淀(ChIP)评估 DNMT1/DNMT3a/DNMT3b 在 miR-142-5p 启动子区域的富集情况,发现宫颈癌中 miR-142-5p 呈高甲基化状态。miR-142-5p 与 PIK3AP1 之间存在靶标结合关系,表明 miR-142-5p 靶向并抑制 PIK3AP1 的表达。进行了失活和功能获得实验以确定 miR-142-5p 和 PIK3AP1 在宫颈癌细胞中的作用。CCK-8、流式细胞术和 Transwell 检测结果显示,在宫颈癌细胞中过表达 miR-142-5p 下调了 PIK3AP1,抑制了 PI3K/AKT 信号通路,导致宫颈癌细胞增殖、迁移和侵袭能力降低,而凋亡能力增强。综上所述,miR-142-5p 通过表观遗传调控靶向 PIK3AP1 使其失活,从而抑制宫颈癌的发展,为宫颈癌的治疗提供了新的靶点。